Evan Greif

Evan Greif is a principal in Bain Capital’s Life Sciences team, which he joined in 2020. Before Bain Capital, he worked at Orbis Investments as an analyst responsible for healthcare. Earlier in his career he was an associate consultant at Bain & Company. His professional background therefore combines healthcare investment analysis with management consulting. [Bain Capital biography](https://www.baincapitallifesciences.com/people/evan-greif).

Greif studied applied mathematics and statistics at Harvard University, earning a bachelor’s degree and a master’s degree. He also completed a master’s in pure mathematics at Cambridge University. Alongside his investment work, he serves as a non-executive director of OMass Therapeutics, the Oxford biotechnology company developing small-molecule medicines. OMass lists him among its board members, separately from its executive management team. [OMass board](https://www.OMass.com/team/).